Safety and efficacy of plerixafor dose escalation for the mobilization of CD34
+
hematopoietic progenitor cells in patients with sickle cell disease: interim results
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34
+
hematopoietic progenitor cells in patients with sickle cell disease: interim results
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now